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Abstract
Background Diagnosis and early treatment of develop-
mental dysplasia of the hip (DDH) continue to be issues of
discussion. In 1992, a nationwide general ultrasound
screening program using Graf technique was introduced to
detect DDH in Austria. We investigated the effects of this
program on the rates of operative and conservative inter-
ventions and the influence of the program on the number of
hospital admissions for the treatment of DDH.
Methods All cases of DDH documented in Austrian
hospitals from 1992 to 2008 were included in this retro-
spective study. The database of the Austrian Ministry of
Health was used to extract documented diagnoses and
treatments.
Results Since the introduction of the screening program,
the number of patients who require pelvic surgery to treat
DDH has decreased by 46 % and the number of open
reductions is as low as 0.16 per 1,000 live births. Hospital
admissions for the treatment of DDH decreased from 9.5 to
3.6 per 1,000 live births. All noted results gained statistical
significance.
Conclusion Compared with routine clinically based
screening programs, our results confirm low numbers of
open reductions and pelvic surgeries. We, therefore,
advocate a standardized nationwide general ultrasound
screening program to reduce the rates of operative inter-
ventions and hospital admissions associated with the
treatment of DDH.
Level of evidence Level III, diagnostic
Keywords DDH  Hip sonography  Treatment rate 
Open reduction rate
Introduction
Until the late 1980s, detection of developmental dysplasia
of the hip (DDH) was based on voluntary clinical exam-
inations performed by a pediatrician or an orthopaedic
specialist at the time when the patient was 3–6 months old.
The range of hip abduction and instability were tested with
Ortolani and Barlow signs. In cases of unclear diagnosis,
radiography of the pelvis was performed. General use of
ultrasound for hip screening within the first days or weeks
after birth began in the early 1980s. Early reports showed
promising results [1, 2].
The nationwide Austrian hip screening program was
introduced in 1992. It consists of clinical examination and
sonographic static and dynamic imaging of the hips using the
method presented by Graf [3]. With this program, two
examinations are scheduled: the first sonogram shortly after
birth and the second at the age of 6–8 weeks [4]. Debate still
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continues regarding how to screen for DDH. Some authors
believe that clinical examination is sufficient [5]. Others
report data on the importance of selective [6–8] or general
ultrasound screening programs [9–13]. No consensus has
been reached regarding how to define a pathological hip, the
natural course of a dysplastic hip joint, the significance of
morphological abnormalities of the hip, or which pathology
should be diagnosed. It is still unclear if only unstable or
dislocated hips should be diagnosed, or dysplastic hip joints
should be detected as well in order to prevent osteoarthritis.
Prospective randomized blinded studies to assess the natural
course of DDH are not available, and no evidence of the best
screening policy and method has been presented. A meta-
analysis of publications in the English language literature on
DDH screening conducted by the US Preventive Services
Task Force [14] concluded, ‘‘Screening with clinical
examination or ultrasound can identify newborns at
increased risk for DDH, but because of the high rate of
spontaneous resolution of neonatal hip instability and dys-
plasia and the lack of evidence of the effectiveness of
intervention on functional outcomes, the net benefits of
screening are not clear.’’
Evidence for the effectiveness of a screening program
could be adduced by evaluating the results of a nationwide
screening program with a timeline spanning several years.
We report the first nationwide database analysis and pres-
ent the results of the Austrian hip screening program from
1992 to 2008. Our goal was to provide answers to the
following questions: Does ultrasound screening for DDH
lead to over-diagnosis and increased conservative treat-
ment rates? Could the number of first hospital admissions
be reduced? Could the number of first surgical procedures
be reduced?
Patients and methods
Data were collected from the Austrian Federal Ministry of
Health, the Austrian Health Institute (known as O¨BIG), which
is an agency that monitors and controls the Austrian Health
Care system, and the Main Association of Austrian Social
Security Institutions. Only data from these sources were
included for patients who were treated for DDH. To search
diagnosis-related codes, we used the International Classifi-
cation of Diseases, Ninth Revision (ICD-9) code 754.3 up to
the year 2001 and ICD, Tenth Revision (ICD-10) codes Q65.0
through Q65.8 from 2001 through 2008. These codes refer to
hip dysplasia and congenital hip dislocation and are listed in
Table 1.
For analysis of treatment, it was important to obtain the
exact number of treated patients, not the number of cases,
because only the first hospital admission or surgery was to be
included in the study. To test for statistical significance of the
results, Poisson regression tests were conducted to identify
trends during the timeline. For data interpretation, the influ-
ence and impact of the development of the annual birthrate,
immigration of children from countries without ultrasound
screening of the hip, and the number of ‘‘medical tourists’’
who came to Austria just for hip surgery had to be evaluated.
The total number of inpatient first admissions (ICD-9
code 754.3 and ICD-10 codes Q65.0 through Q65.8) per
year was calculated. Subgroups of patients from birth to
age 2 years and from birth to age 4 years were formed.
Four types of surgical intervention were classified for
separate evaluation: type 1, open reduction (MEL 4223); type
2, acetabuloplasty (MEL 4222); type 3, pelvic osteotomy
(MEL 4206); and type 4, periacetabular osteotomy and/or
triple osteotomy (MEL 4211). The number of surgeries was
calculated per 1,000 births per year. Data concerning open
reduction in all age groups are available from 1991 onward,
and for the age group from birth to age 4 years as of 1993. For
pelvic osteotomy and triple osteotomy, the oldest available
data date back to 1992. Data for acetabuloplasties have been
documented since 1993. Poisson regressions were calculated
to detect trends in the development of rates. Adaptation of the
p value for simultaneous hypothesis testing was accomplished
by Bonferroni correction. Predictors from these Poisson
regressions were included in the plots.
Results
The birthrate in Austria has been declining over the years
(Fig. 1). This has to be taken into account when measuring
the clinical results.
Does ultrasound screening for DDH lead to over-
diagnosis and increased conservative treatment rates?
In 2008, the occurrence of conservative treatment, defined
as use of Pavlik harness, abduction splint, and plaster cast,
was 2.6 %.
Table 1 ICD-10 codes referring to hip dysplasia and congenital hip
dislocation
ICD-10 code Disease
Q65.0 Congenital dislocation of the hip; unilateral
Q65.1 Congenital dislocation of the hip; bilateral
Q65.2 Congenital dislocation of the hip; unspecified
Q65.3 Congenital subluxation of the hip; unilateral
Q65.4 Congenital subluxation of the hip; bilateral
Q65.5 Congenital subluxation of the hip; unspecified
Q65.6 Unstable hip
Q65.8 Other congenital deformities of the hip
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Could the number of first hospital admissions be
reduced?
The number of first admissions to the hospital because of hip
dysplasia and/or hip dislocation for all age groups studied
declined by 62 %, from 9.5 to 3.6 per 1,000 live births during
the timeline. The decrease was statistically significant, and
significance remained after testing with Bonferroni correction
(p \ 0.001). The full potential of the screening program was
observed 2 years after its introduction.
Figures 2a, b and 3a, b show the decline in numbers of
first admissions to the hospital for treatment of DDH (ICD-
9 code 754.3 and ICD-10 codes Q65.0 through Q65.8).
Could the number of first surgical procedures be
reduced?
Between 1992 and 2008, the number of surgical interven-
tions (acetabuloplasty, pelvic osteotomy, triple osteotomy,
periacetabular osteotomy) declined from 1.3 to 0.7 per
Fig. 1 Total number of births
in Austria
Fig. 2 Inpatient first
admissions per 1,000 births in
all age groups. a Per region. b In
Austria
Fig. 3 Inpatient first
admissions per 1,000 births in
patients from birth to age
4 years. a Per region. b In
Austria
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1,000 live births, a reduction of 46 %. It is notable that
between 1993 and 1995, during the introduction phase of
the use of ultrasound for screening, there was a decrease in
numbers significantly stronger than during the years from
1995 to 2008 because of an overlap from prescreening
years (p = 0.026). However, significance did not persist
after multiple hypotheses testing. Nevertheless, the strong
influence of ultrasound screening on number of surgeries is
shown by the strong decrease in numbers. Such an alter-
ation could not be observed for open reductions. The
number of open reductions remained unchanged at 0.23 per
1,000 live births (including all age groups and all cases
from unscreened pools), which is a very low level. A total
of 342 open reductions were performed in the group of
patients from birth to 4 years. This group includes Aus-
trian-born patients and patients from other countries.
Among these, 74 (22 %) interventions were performed in
children born outside Austria in countries without ultra-
sonography services for screening the hip, and 44 (13 %)
were performed in children born in countries with ultra-
sound screening (e.g., Germany, Czech Republic). The
number of open reductions performed in children born in
Austria was, therefore, 224. Considering only the age
group younger than 4 years, the number of open reductions
was as low as 0.16 per 1,000 live births. The relatively high
number of children from an unscreened population born
outside Austria and the relatively high percentage of chil-
dren coming just for the intervention from abroad leads to a
further decrease of the number of open reductions in
children born in Austria to 0.12 per 1,000 live births.
Discussion
Developmental dysplasia of the hip and its natural history
is still not well understood. The term encompasses a dis-
ease spectrum ranging from a stable hip with a mildly
dysplastic acetabulum to complete hip dislocation. A
clinical hip screening based just on diagnosing hip insta-
bility using the Ortolani or Barlow test and asymmetry in
abduction detects just the tip of the iceberg, namely only
the dislocated, subluxated or unstable hips. Hip patho-
morphology without instability cannot be diagnosed with-
out the use of an imaging technique. The significance of
morphological abnormalities is unknown and one may still
believe that sonographically diagnosed dysplastic hips are
simply immature hips that will mature independently. But
there is evidence that this may not be the case. Engesaeter
et al. [15] published a report on the prevalence of radio-
logical features associated with hip dysplasia in a popula-
tion of 2,081 19-year-old Norwegians. A center-edge angle
of \20 was seen in 3.3 % of the cohort. Ipach et al. [16]
showed that hip arthroplasty in young adults is mostly
indicated because acetabular dysplasia might be the cause
of the onset of osteoarthritis. This is supported by Clohisy
et al. [17] who found that 48 % of 337 patients \50 years
of age undergoing hip arthroplasty had had acetabular
dysplasia. Engesaeter et al. [18] also reported that, unex-
pectedly, only 8 % of those who underwent THR due to
dysplasia were reported to have had unstable hips at birth.
Lee et al. [19] concluded that in 209 of 311 patients who
underwent periacetabular osteotomy, acetabular dysplasia
had not been diagnosed before adolescence.
This allows for drawing the conclusion that a screening
program which is focused only on diagnosing unstable or
dislocated hips is unable to detect acetabular dysplasia and
to prevent surgical interventions like periacetabular oste-
otomy or hip arthroplasty at young age.
Because of this, in 2011, a selective neonatal ultrasound
screening was recommended by the ESPR (European
Society of Paediatric Radiology) task force group on DDH
with an indication based on family history of DDH, breech
presentation and positive clinical findings. It was estimated
that between 12 and 16 % of all newborns will have been
defined as ‘‘at risk’’. This recommendation was mainly
based on two randomised controlled trials from Scandina-
via [8, 12].
Clarke et al. [20] reported an indication for selective
ultrasound screening in 18 % due to clinical signs, and in
3.6 % due to risk factors, with a treatment occurrence of
7.2/1,000 and an incidence of late presented cases of 0.34/
1,000. Selective screening based on risk factors has been
also proposed by Myers et al. [5]. Breech position, family
history, female gender, oligohydramnios, congenital
anomalies, and primiparity were considered to be risk
factors. Evidence, however, is valid for positive family
history only in first-degree family members [19].
There is no consensus about the value and significance
of risk factors, however. Commonly known risk factors
were not clinically important markers of DDH. Risk factors
for DDH did not predict hip dysplasia in adolescents and
adults. Only 16 % of patients undergoing periacetabular
osteotomy had risk factors while ultrasound screening of a
risk group did not reduce the incidence of surgery [21].
Although a selective ultrasound screening may decrease
the number of surgical treatments for infant dysplasia and
instability, its impact on the incidence of DDH and surgical
treatment in skeletally mature patients is rather uncertain.
In conclusion, this means that there is a group of patients
with acetabular dysplasia who had stable hips and no risk
factors at birth but later presented with a painful hip in
adolescence or early adulthood, or they were still asymp-
tomatic but met radiographic criteria with a center-edge
angle \20 [15].
Lee et al. [19] raised the hypothesis that this group
represents a milder variant of infantile DDH that eluded
6 J Child Orthop (2014) 8:3–10
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detection at birth, or another distinct form of hip disease.
Infantile dysplasia entails dislocated, subluxated, or
unstable hips, which are diagnosed by neonatal physical
examination. Adolescent-diagnosed and adult-diagnosed
dysplasia are related to acetabular malformation that is
diagnosed radiographically after symptoms develop. This
idea is not new. In 1970 Wynne-Davis et al. [22] were the
first to postulate that there may be two distinct types of hip
dysplasia—a group with joint laxity that results in neonatal
hip instability, and a group with dysplasia of late onset. A
genetic disposition is discussed but could be proven in few
cases only [23] .
There is no consensus how ‘‘late onset’’ is defined and
how, and if mild/moderate dysplasia is classified on
radiographs. In most studies the term is used just for missed
cases of hip dislocation which had to be treated by open
reduction after walking age. Only a few prospective studies
with a follow-up of more than 20 years, or retrospective
population studies reporting national healthcare data are
published [5, 9]. The question is whether cases of acetab-
ular dysplasia with a ‘‘potential for late presentation’’ could
be detected by a screening program which is based on
clinical testing for instability and on ultrasound for detec-
tion of dysplasia. As randomized prospective studies would
not fulfil the requirements for ethical approval, only pop-
ulation-based studies with analysis of all available national
healthcare data concerning DDH could give an answer. We
are reporting the results of the Austrian neonatal hip
screening program which consists of clinical tests and
ultrasound since its introduction in 1992.
Our study has several limitations. A nationwide study
cannot be conducted in a prospective academic high-
quality setting. The study is a retrospective register-based
nationwide report which reflects the reality of detection and
treatment of DDH in the Austrian population.
Another limitation is the lack of reliable data concerning
the time before the hip sonography screening program has
been introduced. A standardized and computer registered
coding system for diagnosis and treatment was not avail-
able in Austria before 1992. In the same year, the hip
sonography screening program was introduced in national
health care as an examination for newborns (Mutter–Kind
Pass, ‘‘Mother child passport’’). Therefore, statistical data
of a longer timeline reaching back to the 1980s were not
available to allow a comparison of the results with the
previous period and to deliver even clearer results in favour
of the screening program. However, for interpretation of
the statistical data, 1992 was not time zero for hip sonog-
raphy screening. Since 1980, after the introduction of hip
sonography by Graf et al. [24], a continuously growing
number of health care institutions and paediatricians or
orthopaedic physicians provided sonographic examinations
of newborns in Austria. Therefore, the newborn population
delivered shortly before 1992 was already a voluntary
screened one. Therefore, the screening results have to be
compared with published data from other relevant studies.
Conservative treatment
In central Europe a treatment occurrence of 2.6 % seems to
be a reasonable number in relation to the prevalence of hip
dysplasia (including dislocation and instability) [1, 3]. The
MBRN (Medical Birth Registry of Norway) reported a
neonatal hip instability incidence of 0.88 % between 1967
and 2004 [18]. The Norwegian data about the prevalence of
hip dysplasia in a cohort of 19-year-old patients by radio-
graphic classification report a center-edge angle \20 in
3.3 %. A prevalence of sonographically classified patho-
logical hips (type IIc, IId, III, IV according to the Graf
classification system) is reported between 1.3 and 2.4 %
[25–27]. There is evidence that a certain percentage of
pathological hips will grow to be normal spontaneously.
However, this is a matter of fact in any prevention program
and cannot be counted as overtreatment.
The concern that any abduction treatment of the dislo-
cated hip bears the risk of avascular necrosis of the femoral
head was contradicted in a Norwegian study which repor-
ted an incidence of 0 % in a collective of 2,038 newborns
using abduction splints [28, 29] .
Reduction of number of hospital admissions
The impact of a general trend to outpatient treatment of
paediatric orthopaedic diseases is responsible for a certain
part of the decrease of hospital admissions. The main
reason, however, for the significant reduction is that neo-
natal ultrasound screening allows early diagnosing hip
pathology, which results in shorter and less invasive kinds
of treatment [13, 25, 30].
Reduction of number of first surgical interventions—
open reduction
The number of open reductions could be reduced to 0.23
per 1,000 newborns including all open reductions regard-
less of age and whether they had undergone hip sonogra-
phy screening or not. Considering only the age group
younger than 4 years, the number of open reductions was
as low as 0.16 per 1,000 live births. Excluding the rela-
tively high number of children from an unscreened popu-
lation born outside Austria, the number was 0.12 per 1,000
live births (Fig. 4a, b). Reported numbers of open reduc-
tion vary from 0.15 to 3.00 depending on the screening
program used (Fig. 5; Table 2) [5–13, 32–35].
J Child Orthop (2014) 8:3–10 7
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Reduction of number of pelvic osteotomies
and periacetabular osteotomies
Figure 4c shows a significant (p \ 0.001) decline of pelvic
osteotomies and acetabuloplasties. The decline was stron-
ger during the 2 years after the introduction of the
screening than during the following years. A progressing
decrease in the number of pelvic-osteotomies of 46 %
between 1992 and 2008 is promising. Further reduction is a
reliable prediction. This would prove our hypothesis that
the term DDH does not comprise two different pathologic
entities which develop at different ages. The ‘‘adolescent-
adult type of DDH’’ is already present at birth and could be
detected by sonography. Up to now, there are no reports
about patients without an underlying neuromuscular dis-
ease and with a history of a normal hip sonography at birth,
but acetabular dysplasia and subsequent necessary pelvic
osteotomy.
Fig. 4 a First open reductions
(OP) per 1,000 births, including
native Austrians and
immigrants. A very low number
is shown for all age groups.
b First open reductions per
1,000 births in patients from
birth to age 4 years. c First
acetabuloplasties, pelvic
osteotomies, and triple
osteotomies per 1,000 births
8 J Child Orthop (2014) 8:3–10
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Timing for ultrasound screening
Another controversial issue is the first hip sonography
investigation during the first week after birth. Despite the
fact that the screening is a scheduled examination in
Austria, not every hospital provides that service.
Another fact to be taken into consideration is that the
number of 1-day admission births, home births, and births
in private clinics not providing orthopaedic service, is
increasing. It also has to be noted that routine sonographic
examinations at birth might deliver doubtful results, such
as immature-looking hips that usually resolve spontane-
ously within the first weeks of life. The prevalence of Graf
type IIa hips in neonates is approximately 20 %, which
bears a potential risk for overtreatment [26]. Hip joints that
are classified as type IIa look like dysplastic hip joints but
are normal at that age. It is known that at 12 weeks after
birth, only 11 % of former type IIa hip joints remain, being
classified as type IIb from that time on [31].
Based on our findings, the ideal time for universal hip
screening, including sonography, is 4–6 weeks after birth.
This recommendation is also supported by von Kries et al.
[13] and Grill et al. [32]. At that time, it is easy to provide a
universal high-quality sonographic examination because
the babies can be brought to selected screening centers with
specifically trained staff. Only those who have clinically
obvious pathological abnormalities and those who have a
positive first-degree family history of DDH require an
earlier sonographic examination, which should be man-
ageable for the smaller patient group.
Conclusion
The results of the Austrian hip sonography screening pro-
gram show a distinct and progressing decrease of hip sur-
geries in adolescents and young adults. Our data support
the effectiveness of this program and the hypothesis that by
using ultrasound, the so-called adolescent and young adult
type of DDH could be detected as well. A selective
screening program may just be compromising.
Based on the results of our study, general ultrasound
screening of the hip at the age of 4–6 weeks, together with
a clinical examination must be recommended.
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